Industry Briefing
A single destination for timely, editor-curated robotics news from around the world.
Myriam Heiman named director of The Picower Institute for Learning and Memory
Heiman, a prominent researcher specializing in neurodegenerative diseases including Huntington’s and Parkinson’s, has been appointed to lead the institute starting July 1. This leadership transition aims to enhance the institute's focus on groundbreaking research and innovative treatments for these debilitating conditions. Heiman's extensive expertise and commitment to advancing the understanding of neurodegenerative disorders are expected to drive the institute's initiatives forward, fostering collaboration and discovery in the field. The appointment reflects the institute's dedication to addressing the growing challenges posed by these diseases, which affect millions globally.
Leadership Faculty Brain and cognitive sciences Neuroscience Disease Parkinson's
ElliQ is a surprisingly helpful companion robot for older adults
A neurologist recently advised a family to help rebalance the life of a woman suffering from Parkinson's disease, as her medication had been losing effectiveness over the past month. This decline in her treatment led to a noticeable reduction in her engagement in essential activities such as exercising, socializing, and pursuing hobbies. In response to this situation, the family is introducing the ElliQ robot, designed to assist individuals in maintaining a more active and connected lifestyle. The robot's arrival is expected to provide support and encouragement, potentially helping the woman regain her motivation and improve her overall quality of life. The integration of technology into her daily routine aims to address the challenges posed by her condition and enhance her engagement with both physical and social activities.
Gadgets Smart Home Tech
Beacon Biosignals is mapping the brain during sleep
Jake Donoghue, a PhD graduate from MIT, and former MIT researcher Jarrett Revels have launched a company focused on developing an AI-driven platform aimed at diagnosing and treating diseases. This innovative initiative seeks to leverage advanced artificial intelligence technologies to enhance medical decision-making and improve patient outcomes. The platform is currently in development, with the founders drawing on their extensive research backgrounds to create a solution that addresses critical challenges in healthcare. By integrating AI into the diagnostic process, the company aims to streamline the identification of diseases and facilitate more effective treatment plans. The project reflects a growing trend in the medical field, where technology is increasingly being utilized to augment traditional healthcare practices.
Startups Alumni/ae Alzheimer's Parkinson's Disease Neuroscience
